May the FORS be with you: a system sequel.


Journal

Immunohematology
ISSN: 0894-203X
Titre abrégé: Immunohematology
Pays: United States
ID NLM: 8806387

Informations de publication

Date de publication:
Jan 2020
Historique:
entrez: 24 4 2020
pubmed: 24 4 2020
medline: 7 7 2020
Statut: ppublish

Résumé

This article is an update of the review of the FORS system published in Immunohematology in 2017 (Hult AK, Olsson ML. The FORS awakens: review of a blood group system reborn. Immunohematology 2017;33:64-72). This update incorporates the most recently presented knowledge on this still enigmatic system and its genetic, enzymatic, and immunological aspects. Further insight into the genetic variation and allele frequencies of the GBGT1 locus has been reported, and screening studies regarding the prevalence of naturally occurring anti-FORS1 in human plasma have been performed and presented. More basic knowledge on the specificity of the gene product, the Forssman synthase, has been obtained in several detailed studies, and its relation to the homologous ABO gene has been investigated. Taken together, we summarize recently added information about the carbohydrate-based FORS blood group system (International Society of Blood Transfusion number 031).

Identifiants

pubmed: 32324040

Substances chimiques

ABO Blood-Group System 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14-18

Auteurs

Annika K Hult (AK)

Postdoctoral Researcher, Department of Clinical Immunology and Transfusion Medicine, Office of Medical Services, Region Skåne, and Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University.

Martin L Olsson (ML)

Medical Director of the Nordic Reference Laboratory for Genomic Blood Group Typing and Senior Consultant at the Department of Clinical Immunology and Transfusion Medicine, Office of Medical Services, Region Skåne, Sweden; and Vice Dean of the Faculty of Medicine, Professor of Transfusion Medicine at the Department of Laboratory Medicine, Division of Hematology and Transfusion Medicine, Lund University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH